NL6608255A - - Google Patents

Info

Publication number
NL6608255A
NL6608255A NL6608255A NL6608255A NL6608255A NL 6608255 A NL6608255 A NL 6608255A NL 6608255 A NL6608255 A NL 6608255A NL 6608255 A NL6608255 A NL 6608255A NL 6608255 A NL6608255 A NL 6608255A
Authority
NL
Netherlands
Application number
NL6608255A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL6608255A publication Critical patent/NL6608255A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/09Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems
    • C07D489/10Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14
    • C07D489/12Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14 the bridge containing only two carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NL6608255A 1965-06-15 1966-06-14 NL6608255A (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB25289/65A GB1136214A (en) 1965-06-15 1965-06-15 Thebaine and oripavine derivatives

Publications (1)

Publication Number Publication Date
NL6608255A true NL6608255A (xx) 1966-12-16

Family

ID=10225305

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6608255A NL6608255A (xx) 1965-06-15 1966-06-14

Country Status (14)

Country Link
AT (1) AT272530B (xx)
BE (1) BE682551A (xx)
BR (1) BR6680359D0 (xx)
CH (1) CH558362A (xx)
DE (1) DE1620206A1 (xx)
DK (1) DK115926B (xx)
ES (1) ES327925A1 (xx)
FI (1) FI49724C (xx)
FR (1) FR6395M (xx)
GB (1) GB1136214A (xx)
LU (1) LU51306A1 (xx)
NL (1) NL6608255A (xx)
NO (1) NO119590B (xx)
SE (1) SE325276B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2554816B1 (fr) * 1983-11-16 1986-09-26 Sanofi Sa Nouveau derive de la nororipavine presentant a la fois une activite agoniste et antagoniste des recepteurs morphiniques
KR100204659B1 (ko) * 1996-05-28 1999-06-15 강재헌 신규한 부프레노핀계 진통제용 화합물
AUPQ968300A0 (en) 2000-08-25 2000-09-21 Glaxo Wellcome Australia Ltd Chemical methods
GB2388369B (en) 2002-05-10 2004-05-05 Reckitt Benckiser Healthcare Demethylation of thebaine derivative
GB0421687D0 (en) 2004-09-30 2004-11-03 Johnson Matthey Plc Preparation of opiate analgesics
CA2614223A1 (en) 2005-02-24 2006-08-31 Dr Pharma Nova, Llc A registry method and control system for dea schedule ii-v medicines
DE102006054731B4 (de) 2006-11-21 2013-02-28 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie
RS53154B (en) * 2008-07-30 2014-06-30 Purdue Pharma Lp ANALYSIS OF BUPRENORPHINE
PL2342207T3 (pl) 2008-09-30 2016-05-31 SpecGx LLC Sposoby alkilowania norbuprenorfiny ze zmniejszonym powstawaniem zanieczyszczeń
NZ595591A (en) 2009-04-24 2013-11-29 Univ Brock Processes for the preparation of morphinane and morphinone compounds
GB201111775D0 (en) 2011-07-08 2011-08-24 Univ Bath Compounds and uses thereof
EP2790685B1 (en) 2011-12-12 2017-08-16 LTS LOHMANN Therapie-Systeme AG Transdermal delivery system comprising buprenorphine
EP2877155B1 (en) 2012-07-26 2020-10-28 Camurus AB Opioid formulations
AR094641A1 (es) * 2012-12-07 2015-08-19 Purdue Pharma Lp Análogos de buprenorfina
GB2529789A (en) 2013-06-04 2016-03-02 Lohmann Therapie Syst Lts Transdermal Delivery system
CA3238849A1 (en) 2021-12-16 2023-06-22 Arevipharma Gmbh Method of making buprenorphine and precursor compounds thereof

Also Published As

Publication number Publication date
SE325276B (xx) 1970-06-29
ES327925A1 (es) 1967-04-01
DK115926B (da) 1969-11-24
BE682551A (xx) 1966-11-14
DE1620206A1 (de) 1970-03-19
FI49724C (fi) 1975-09-10
BR6680359D0 (pt) 1973-12-26
AT272530B (de) 1969-07-10
FI49724B (xx) 1975-06-02
GB1136214A (en) 1968-12-11
CH558362A (de) 1975-01-31
NO119590B (xx) 1970-06-08
LU51306A1 (xx) 1966-08-16
FR6395M (xx) 1968-10-21

Similar Documents

Publication Publication Date Title
FR6395M (xx)
JPS429480Y1 (xx)
FR1550059A (xx)
JPS433100Y1 (xx)
JPS448391Y1 (xx)
JPS4512000Y1 (xx)
JPS4517779Y1 (xx)
AU5279364A (xx)
AU416352B2 (xx)
JPS4328492Y1 (xx)
JPS4635525Y1 (xx)
JPS457316Y1 (xx)
AU6340065A (xx)
NL6601040A (xx)
BE675686A (xx)
NL6504103A (xx)
BE663127A (xx)
BE665744A (xx)
BE673307A (xx)
BE672967A (xx)
BE665839A (xx)
BE661447A (xx)
BE629703A (xx)
NL6602703A (xx)
BE674035A (xx)